Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

BAUSCH & LOMB ENTERS SKIN CARE MARKET WITH PURCHASE OF CUREL, SOFT SENSE lotion brands from S. C. Johnson, the firm reported May 19. Curel and Soft Sense lotions had combined 1992 sales of $ 45 mil. Slated for completion by the end of June, the acquisition "will not have a material impact on the company's results for 1993," Bausch & Lomb said. Terms of the transaction were not disclosed. S. C. Johnson is retaining Soft Sense shaving gel and said that it will probably rename the product. The firm is continuing to seek a buyer for its Halsa and Agree hair care and Fisher-Price children's toiletries brands. Bausch & Lomb stated that "the further development of [the Curel and Soft Sense lines] will be supported by the company's research and development expertise in formulations used to clean, disinfect or lubricate sensitive tissue, as well as by its extensive distribution organization serving drug, food and mass merchandise channels of trade." According to the firm, Curel, the number three therapeutic hand and body moisturizer line behind Warner-Lambert's Lubriderm and Beiersdorf's Nivea, is "one of the fastest growing participants in that category." Soft Sense ranks in the top five cosmetic lotion brands, the company said. Bausch & Lomb has been actively looking to leverage its contact lens solutions business into other OTC and health and beauty aid areas in recent years. For example, the firm was one of the first to offer an alcohol-free mouthwash, Clear Choice, which was launched in October 1992. The company also has been looking for suitable skin care brands since it identified skin care as an area for growth in the 1980s. An attempt to break into the segment by purchasing an unspecified skin care line from Sterling Winthrop fell through in January. Speculation surrounding the negotiations focused on the pHisoHex Rx and pHisoDerm OTC skin cleansers. Bausch & Lomb indicated that it may pursue other acquisitions or develop products in-house to build its new skin care business. Bausch & Lomb recently repackaged its eye care product offerings beginning with Moisture Drops. Moisture Drops was promoted in a May 2 free-standing insert offering a coupon for a free trial-size dropper or $ 1 off a larger-size dropper. The firm's Allergy Drops, Eye Wash, Duolube and Dry Eye Therapy also will be reintroduced in color-coded packaging intended to highlight the Bausch & Lomb brand name, the company said. The entire Bausch & Lomb repackaged eye care line will be promoted in a June FSI, as well as in print ads in Modern Maturity and Family Circle. The eye care brands also will be the subject of identification spots during TV game shows. Other personal health care products marketed by the firm include the Interplak home plaque removal device.

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts